These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23701810)

  • 1. Cognitive function in older patients with postherpetic neuralgia.
    Pickering G; Pereira B; Clère F; Sorel M; de Montgazon G; Navez M; Picard P; Roux D; Morel V; Salimani R; Adda M; Legout V; Dubray C
    Pain Pract; 2014 Jan; 14(1):E1-7. PubMed ID: 23701810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Clin Drug Investig; 2009; 29(4):231-41. PubMed ID: 19301937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of a lidocaine 5% medicated plaster relative to gabapentin for postherpetic neuralgia in the United Kingdom.
    Dakin H; Nuijten M; Liedgens H; Nautrup BP
    Clin Ther; 2007 Jul; 29(7):1491-507. PubMed ID: 17825701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of a lidocaine 5% medicated plaster compared with pregabalin for the treatment of postherpetic neuralgia in the UK: a Markov model analysis.
    Ritchie M; Liedgens H; Nuijten M
    Clin Drug Investig; 2010; 30(2):71-87. PubMed ID: 20067326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster.
    Wilhelm IR; Tzabazis A; Likar R; Sittl R; Griessinger N
    Eur J Anaesthesiol; 2010 Feb; 27(2):169-73. PubMed ID: 20010108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and impact on quality of life of post-herpetic neuralgia in French medical centers specialized in chronic pain management: the ZOCAD study.
    Laurent B; Vicaut E; Leplège A; Bloch K; Leutenegger E
    Med Mal Infect; 2014 Dec; 44(11-12):515-24. PubMed ID: 25455078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5% lidocaine medicated plaster in elderly patients with postherpetic neuralgia: results of a compassionate use programme in France.
    Clère F; Delorme-Morin C; George B; Navez M; Rioult B; Tiberghien-Chatelain F; Ganry H
    Drugs Aging; 2011 Sep; 28(9):693-702. PubMed ID: 21913735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia.
    Kanai A; Okamoto T; Suzuki K; Niki Y; Okamoto H
    Anesth Analg; 2010 May; 110(5):1457-60. PubMed ID: 20237042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of topical 5% lidocaine-medicated plasters on sleep and quality of life in patients with postherpetic neuralgia.
    Binder A; Rogers P; Hans G; Baron R
    Pain Manag; 2016; 6(3):229-39. PubMed ID: 26821240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine 5% medicated plaster: a review of its use in postherpetic neuralgia.
    Garnock-Jones KP; Keating GM
    Drugs; 2009 Oct; 69(15):2149-65. PubMed ID: 19791831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial.
    Binder A; Bruxelle J; Rogers P; Hans G; Bösl I; Baron R
    Clin Drug Investig; 2009; 29(6):393-408. PubMed ID: 19432499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Postherpetic Neuralgia with 5% Topical Lidocaine Plaster – Experience from a Small County Hospital: Case Report.
    Kontić M; Vičić-Hudorović V; Hudorović N
    Acta Clin Croat; 2016 Dec; 55(4):655-658. PubMed ID: 29117658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Fogliardi A; Brunori C
    Minerva Med; 2013 Dec; 104(6):631-7. PubMed ID: 24316916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy.
    Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
    Curr Med Res Opin; 2009 Jul; 25(7):1677-87. PubMed ID: 19480610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia.
    Sabatowski R; Hans G; Tacken I; Kapanadze S; Buchheister B; Baron R
    Curr Med Res Opin; 2012 Aug; 28(8):1337-46. PubMed ID: 22769236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a metered-dose 8% lidocaine pump spray for patients with post-herpetic neuralgia.
    Kanai A; Kumaki C; Niki Y; Suzuki A; Tazawa T; Okamoto H
    Pain Med; 2009; 10(5):902-9. PubMed ID: 19682274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical pharmacologic approach with 5% lidocaine medicated plaster in the treatment of localized neuropathic pain].
    Provinciali L; Lattanzi S; Chiarlone R; Fogliardi A; Intelligente F; Irace C; Lanzilotta M; Palomba R; Storelli E; Zampi M
    Minerva Med; 2014 Dec; 105(6):515-27. PubMed ID: 25392960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.